home / stock / camrf / camrf quote
Last: | $46.15 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $46.15 |
High: | $0 |
Low: | $0 |
Volume: | 9 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$46.15 | $0 | $46.15 | $0 | $0 | 9 | 04-26-2024 |
$46.15 | $0 | $46.15 | $0 | $0 | 20 | 02-29-2024 |
$46.15 | $46.15 | $46.15 | $46.15 | $46.15 | 197 | 02-22-2024 |
$50.71 | $0 | $50.71 | $0 | $0 | 40 | 02-12-2024 |
$50.71 | $51.65 | $50.71 | $51.65 | $50.71 | 212 | 02-09-2024 |
$50.68 | $50.68 | $50.68 | $50.68 | $50.68 | 344 | 02-05-2024 |
$21.81 | $0 | $21.81 | $0 | $0 | 150 | 11-01-2022 |
$21.81 | $21.81 | $21.81 | $21.81 | $21.81 | 100 | 10-24-2022 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-12-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-11-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-10-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-07-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-06-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-05-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 02-04-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 100 | 02-03-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 01-31-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 01-30-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 01-29-2020 |
$ | $N/A | $9.65 | $N/A | $N/A | 0 | 01-28-2020 |
News, Short Squeeze, Breakout and More Instantly...
Camurus AB Company Name:
CAMRF Stock Symbol:
OTCMKTS Market:
The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence PR Newswire LUND, Sweden , May 3, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) today announced that the Australian regulatory agency, the Therapeutic Good...
Camurus receives positive CHMP opinion for Buvidal 160mg monthly dose for the treatment of opioid dependence PR Newswire LUND, Sweden , March 26, 2021 /PRNewswire/ -- Camurus today announced that the Committee for Medicinal Products for Human Use (CHMP) of the Eu...
Once-weekly formulation of setmelanotide achieved weight loss efficacy comparable to daily-dosing formulation Both weekly and daily formulations of setmelanotide were observed to be safe and well-tolerated LUND, Sweden , June 24, 2020 /PRNewswire/ -- Camurus' partner Rhyt...